Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient

Rationally designed, individualized therapeutic strategies have long been a desired objective for breast cancer patients and clinicians as an estimated 178,480 new cases of invasive breast cancer will be diagnosed among women in the United States this year and over 40,000 women are expected to die from the disease. [1] The increasing appreciation of breast tumor cellular heterogeneity raises fundamental questions as to the relative contributions of cellular subsets to the biologic behavior of an individual patient’s tumor. [2] As such, it has become increasingly clear that in many cases, an individualized strategy for the treatment of breast cancer would be of great benefit, and that the ability to isolate relevant cellular subsets from the main tumor population is one of the critical limits to accomplishing this goal.

Download Full-text

Abstract P2-08-07: Life-years lost to metastatic breast cancer among an annual cohort of women diagnosed with invasive breast cancer in the United States

10.1158/1538-7445.sabcs19-p2-08-07 ◽

2020 ◽

Author(s):

Stephanie Louise Sansom ◽

Kevin C Ward

Keyword(s):

Breast Cancer ◽

United States ◽

Metastatic Breast Cancer ◽

Invasive Breast Cancer ◽

Metastatic Breast ◽

The United States ◽

Life Years ◽

Annual Cohort ◽

Life Years Lost

Download Full-text

NCCN Invasive Breast Cancer Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2007.0025 ◽

2007 ◽

Vol 5 (3) ◽

pp. 246 ◽

Cited By ~ 33

Author(s):

_ _

Keyword(s):

Breast Cancer ◽

United States ◽

Invasive Breast Cancer ◽

Breast Cancer Mortality ◽

The United States ◽

Cancer Society ◽

The Past ◽

Recent Version ◽

Common Malignancy

The American Cancer Society estimates that 214,640 new cases of breast cancer will be diagnosed and 41,430 will die of the disease in the United States in 2006. Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The incidence of breast cancer has steadily increased in the United States over the past few decades, but breast cancer mortality appears to be declining, suggesting a benefit from early detection and more effective treatment. These guidelines discuss diagnosis, treatment, and follow up for invasive breast cancer. For the most recent version of the guidelines, please visit NCCN.org

Download Full-text

Effect of Raloxifene on Invasive Breast Cancer Incidence in Postmenopausal Women From the United States and Canada*

Obstetrics and Gynecology ◽

10.1097/00006250-200604001-00194 ◽

2006 ◽

Vol 107 (Supplement) ◽

pp. 81S-82S

Author(s):

John Mershon ◽

Damon Disch ◽

Sherie Dowsett ◽

Silvana Martino

Keyword(s):

Breast Cancer ◽

United States ◽

Postmenopausal Women ◽

Cancer Incidence ◽

Invasive Breast Cancer ◽

Breast Cancer Incidence ◽

The United States

Download Full-text

Breast Cancer Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2003.0016 ◽

2003 ◽

Vol 1 (2) ◽

pp. 148 ◽

Cited By ~ 24

Keyword(s):

Breast Cancer ◽

United States ◽

Clinical Practice ◽

Clinical Practice Guidelines ◽

Practice Guidelines ◽

Invasive Breast Cancer ◽

The United States ◽

Cancer Society ◽

Nccn Guidelines ◽

Recent Version

The American Cancer Society estimates that approximately 205,000 new cases of breast cancer were diagnosed in the United States in the year 2002, and approximately 40,000 patients will die of this disease. The NCCN guidelines discuss the complex and varied therapeutic options for patients with noninvasive or invasive breast cancer. For the most recent version of the guidelines, please visit NCCN.org

Download Full-text